<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00998816</url>
  </required_header>
  <id_info>
    <org_study_id>ANAE 153-09</org_study_id>
    <nct_id>NCT00998816</nct_id>
  </id_info>
  <brief_title>The Effect of Perioperative Pregabalin on the Incidence of Chronic Post-thoracotomy Pain Syndrome</brief_title>
  <official_title>A Multicenter Prospective Randomized Double-blind Placebo Controlled Trial Assessing the Effect of Perioperative Pregabalin on the Incidence of Chronic Post Thoracotomy Pain Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Queen's University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>McMaster University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Queen's University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pregabalin, administered prior to and following lateral thoracotomy surgery will reduce the&#xD;
      likelihood of chronic post-thoracotomy pain syndrome (CPTPS).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A total of 200 patients scheduled for lateral thoracotomy will be randomly assigned to&#xD;
      receive either placebo or 150 mg pregabalin (Lyrica)1 hour prior to surgery, 12 hr after&#xD;
      surgery and then every 12 hr for an additional 10 days. While in the hospital, patients will&#xD;
      be assessed for pain intensity, satisfaction and side effects. Patients will be re-assessed&#xD;
      at 2, 4 and 6 months following surgery.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    No funding&#xD;
  </why_stopped>
  <start_date>May 2012</start_date>
  <completion_date type="Anticipated">October 2014</completion_date>
  <primary_completion_date type="Anticipated">August 2014</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of chronic post thoracotomy pain syndrome</measure>
    <time_frame>6 months following surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>During hospital stay: pain intensity, PEF and FEV1, patient satisfaction, medication side effects. At 2, 4, and 6 months: pain intensity, pain quality (neuropathic versus other), quality of life, pain interference with daily function</measure>
    <time_frame>During hospital stay and at 2, 4, and 6 months postoperatively</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Chronic Pain</condition>
  <arm_group>
    <arm_group_label>Placebo capsules</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>one placebo capsule will be administered 1 hour before lateral thoracotomy, 12 hours following the thoracotomy and then every 12h BID for 10 days following lateral thoracotomy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>pregabalin capsules</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Pregabalin capsules (150mg) will be administered one hour before lateral thoracotomy, 12 hours following the thoracotomy and then every 12 hours (BID) for 10 days following lateral thoracotomy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Pregabalin</intervention_name>
    <description>pregabalin capsules (150mg,oral) will be administered 1 hour before lateral thoracotomy, 12 hours after the thoracotomy and then 12 h BID for 10 additional days.</description>
    <arm_group_label>Placebo capsules</arm_group_label>
    <arm_group_label>pregabalin capsules</arm_group_label>
    <other_name>Lyrica</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Elective open thoracotomy for primary thoracic surgery, understanding and provision of&#xD;
             written informed consent, ASA class I II or III&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Inability ot adhere to study protocol:&#xD;
&#xD;
               -  intolerance or hypersensitivity to any agents to be used in the study,&#xD;
                  contraindication to thoracic epidural placement&#xD;
&#xD;
               -  inability to respond to the study questionnaire&#xD;
&#xD;
               -  renal insufficiency(serum creatinine &gt; 1.5 upper limit of normal)&#xD;
&#xD;
               -  Body Mass index &gt; 40&#xD;
&#xD;
               -  planned post-operative ventilation.&#xD;
&#xD;
          -  Confounding procedural factors which might affect validity of data:&#xD;
&#xD;
               -  previous ipsilateral thoracotomy&#xD;
&#xD;
               -  surgery for tumor extending into the chest wall&#xD;
&#xD;
               -  rest pain in proposed surgical area pre-operatively&#xD;
&#xD;
               -  chest tube in situ at time of surgery&#xD;
&#xD;
               -  requirement for second thoracotomy or re-occurrence of disease after surgery&#xD;
                  *isolated pleuroscopy or pleurodesis procedures.&#xD;
&#xD;
          -  Potential interaction with study medications and patient's current medications:&#xD;
&#xD;
               -  current alcohol or other substance abuse&#xD;
&#xD;
               -  chronic steroid use&#xD;
&#xD;
               -  pre-existing chronic pain requiring chronic analgesic use&#xD;
&#xD;
               -  history of seizure disorder requiring treatment with an anticonvulsant&#xD;
&#xD;
               -  current therapy with thiazolidinedione class oral hypoglycemic agents (eg, Actos,&#xD;
                  Avandia or Avandamet)&#xD;
&#xD;
               -  history of congestive heart failure&#xD;
&#xD;
               -  major psychiatric disorder&#xD;
&#xD;
               -  any contraindication to use of NSAIDs.&#xD;
&#xD;
          -  Insufficient safety data in the patient population:&#xD;
&#xD;
               -  patients requiring preoperative assistance or assistive device for ambulation,&#xD;
                  pregnant or breastfeeding&#xD;
&#xD;
               -  weight &lt;50 Kg&#xD;
&#xD;
               -  dizziness while inpatient.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jorge E Zamora, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Queen's University/ Kingston General Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dr. Jorge E Zamora</name>
      <address>
        <city>Kingston</city>
        <state>Ontario</state>
        <zip>K7L 2V7</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>April 2012</verification_date>
  <study_first_submitted>October 20, 2009</study_first_submitted>
  <study_first_submitted_qc>October 20, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 21, 2009</study_first_posted>
  <last_update_submitted>April 10, 2012</last_update_submitted>
  <last_update_submitted_qc>April 10, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 11, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Queen's University</investigator_affiliation>
    <investigator_full_name>Jorge Zamora</investigator_full_name>
    <investigator_title>Associate Professor, MD, FRCPC</investigator_title>
  </responsible_party>
  <keyword>thoracotomy</keyword>
  <keyword>chronic</keyword>
  <keyword>pain</keyword>
  <keyword>pregabalin</keyword>
  <keyword>Lyrica</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chronic Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pregabalin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

